UBS

525 results

The debate about whether the Chinese economy will have a “hard landing” continues, with the more bearish among the analysts finding their views suppor(...)

European stock-index futures climbed, following the biggest weekly advance for the region’s equity benchmark in two months, as Chinese economic growth matched forecasts.

European stock-index futures climbed, following the biggest weekly advance for the region’s equity benchmark in two months, as Chinese economic growth(...)

Mining company Alcoa kicked off the US earnings season with results that beat analysts’ estimates.

European stocks rose to their highest level in almost a month as miner Alcoa kicked off the US earnings season with results that beat analysts’ estima(...)

A review of Libor by Financial Conduct Authority boss Martin Wheatley recommended control of the rate be stripped from the British Bankers’ Association. Photograph: Simon Dawson/Bloomberg.

The owner of the New York Stock Exchange is to take control of the controversial interbank lending rate at the heart of the recent banking scandal.NYS(...)

Ryanair closed down almost 3 per cent, although with good volume and slightly higher than its competitors in what overall was a poor day for the aviation industry, blamed on rising oil prices. Photograph: Paul Thomas/Bloomberg

It was another day of gains on European stocks after the European Central Bank said interest rates would remain low. US markets, back from their July (...)

Former UBS and Citygroup trader Tom Hayes arrives at Westminster Magistrates Court where he will face trial on eight charges of conspiracy to defraud, in connection with the investigation by the Serious Fraud Office, into the manipulation of the Libor interbank lending rate. Photograph: Lewis Whyld/PA Wire.

Tom Hayes, the former UBS and Citigroup trader, is scheduled to enter a plea on charges related to manipulation of the London interbank offered rate l(...)

     S&P maintained its ratings for UBS because it considers the Zurich-based company to be ‘the most active bank in reducing its exposures to investment banking. Photograph:   Spencer Platt/Getty Images

Barclays, Deutsche Bank and Credit Suisse had their credit ratings lowered by Standard & Poor’s as new rules and “uncertain market conditions” thr(...)

Shareholders may have bloodied the nose of Elan management with their rejection of its investment plans at Monday’s extraordinary general meeting but, in its most recent update, Royalty had secured acceptances of less than 8 per cent of Elan’s stock.

Royalty Pharma has only itself to blame for the failed hostile bid to acquire Irish biotech group Elan for up to $8 billion. The Dublin-headquartered (...)

Britain’s fraud prosecutor today charged a former UBS trader with conspiracy to defraud, as part of a global investigation into the manipulation of benchmark interest rates. Photo: Bloomberg

Britain’s fraud prosecutor today charged former UBS trader Tom Hayes with eight counts of conspiracy to defraud, as part of a global investigation int(...)

While Royalty Pharma boosted its unsolicited offer to as much as $15.50 a share this month, at least five analysts covering Dublin-based Elan see the stock falling if that bid disappears

Elan shareholders risk losing $2 billion by listening to the company’s board and rejecting Royalty Pharma’s takeover bid, according to market analysts(...)

  • « First
  • Prev
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • Next
  • Last »